SANDRA MOSTARD: Open Payments
NPI 1053759837 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,104 in 35 payments from 20 companies in 2025. Trend: 2023 $350 · 2024 $1,047 · 2025 $1,104
Food & beverage: $1,104
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 6 | $204 |
| PFIZER INC. | 3 | $150 |
| GENZYME CORPORATION | 1 | $125 |
| EMD Serono, Inc. | 1 | $124 |
| Daiichi Sankyo Inc. | 3 | $73 |
| Novartis Pharmaceuticals Corporation | 3 | $70 |
| Gilead Sciences, Inc. | 3 | $49 |
| Merck Sharp & Dohme LLC | 2 | $47 |
| TerSera Therapeutics LLC | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
Products named: OPDIVO, ELREXFIO, SARCLISA, BREYANZI, Trodelvy, INJECTAFER, KISQALI, LUTATHERA.
Industry payments across NC — which companies pay providers there.
